Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jeffrey Olsen

Concepts (206)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rectal Neoplasms
12
2024
160
3.910
Why?
Chemoradiotherapy
12
2024
238
2.530
Why?
Radiosurgery
8
2020
398
2.140
Why?
Radiotherapy, Intensity-Modulated
5
2019
143
1.730
Why?
Gastrointestinal Neoplasms
6
2020
74
1.620
Why?
Anus Neoplasms
3
2019
33
1.600
Why?
Radiotherapy Planning, Computer-Assisted
7
2020
150
1.590
Why?
Neoadjuvant Therapy
11
2024
475
1.550
Why?
Liver Neoplasms
8
2020
776
1.480
Why?
Adenocarcinoma
11
2024
927
1.310
Why?
Carcinoma, Hepatocellular
5
2019
370
1.160
Why?
Radiotherapy, Image-Guided
5
2020
40
1.090
Why?
Radiation Oncology
4
2025
83
0.990
Why?
Esophageal Neoplasms
4
2024
351
0.890
Why?
Carcinoma, Squamous Cell
4
2017
628
0.890
Why?
Pancreatic Neoplasms
8
2022
944
0.860
Why?
Imagination
1
2024
20
0.800
Why?
Technology
1
2024
100
0.770
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2024
1998
0.720
Why?
Prostatic Neoplasms
4
2015
972
0.710
Why?
Tomography, X-Ray Computed
9
2020
2786
0.700
Why?
Colorectal Neoplasms
3
2021
874
0.680
Why?
Radiotherapy Dosage
8
2020
289
0.650
Why?
Magnetic Resonance Imaging
7
2021
3926
0.650
Why?
Magnetic Resonance Imaging, Interventional
2
2019
30
0.620
Why?
Thoracic Neoplasms
2
2016
40
0.590
Why?
Abdominal Neoplasms
2
2016
48
0.580
Why?
Lymphatic Irradiation
1
2019
11
0.580
Why?
Uterine Cervical Neoplasms
2
2012
269
0.540
Why?
Deglutition Disorders
1
2018
159
0.480
Why?
Intestine, Small
2
2017
160
0.480
Why?
Organs at Risk
5
2020
37
0.480
Why?
Tumor Burden
6
2018
326
0.480
Why?
Humans
52
2025
146342
0.420
Why?
Fluorouracil
5
2019
231
0.420
Why?
Aged, 80 and over
16
2019
8391
0.420
Why?
Fluorodeoxyglucose F18
2
2012
164
0.420
Why?
Multimodal Imaging
2
2012
137
0.410
Why?
Catheter Ablation
1
2018
355
0.410
Why?
Induction Chemotherapy
4
2024
87
0.400
Why?
Neoplasms
2
2020
2954
0.390
Why?
Positron-Emission Tomography
2
2012
343
0.390
Why?
Prostate-Specific Antigen
1
2013
162
0.370
Why?
Prone Position
1
2012
26
0.360
Why?
Supine Position
1
2012
39
0.360
Why?
Neoplasm Recurrence, Local
2
2021
1160
0.340
Why?
Serpins
1
2010
28
0.320
Why?
Image Interpretation, Computer-Assisted
1
2012
295
0.310
Why?
Movement
2
2011
290
0.300
Why?
Middle Aged
22
2024
36619
0.290
Why?
Biomarkers, Tumor
3
2018
1339
0.290
Why?
Radiopharmaceuticals
3
2018
210
0.290
Why?
Aged
19
2024
26432
0.280
Why?
Diagnostic Imaging
2
2024
340
0.280
Why?
Antigens, Neoplasm
1
2010
271
0.280
Why?
Imaging, Three-Dimensional
1
2012
582
0.280
Why?
Carcinoma, Non-Small-Cell Lung
3
2013
1195
0.270
Why?
Mitomycin
2
2019
31
0.270
Why?
Early Detection of Cancer
1
2013
506
0.270
Why?
Tomography, Spiral Computed
1
2007
30
0.260
Why?
Lung Neoplasms
5
2013
2675
0.260
Why?
Neoplasm Staging
5
2023
1488
0.260
Why?
Yttrium Radioisotopes
2
2018
64
0.250
Why?
Respiration
1
2007
208
0.250
Why?
Antineoplastic Agents
2
2019
2219
0.240
Why?
Disease-Free Survival
4
2017
778
0.220
Why?
Radiotherapy
2
2017
209
0.220
Why?
Risk Management
1
2025
81
0.220
Why?
Algorithms
3
2015
1849
0.220
Why?
Embolization, Therapeutic
2
2018
246
0.210
Why?
Combined Modality Therapy
3
2024
1271
0.210
Why?
Medical Errors
1
2025
124
0.210
Why?
Lymphatic Metastasis
2
2019
335
0.200
Why?
Treatment Outcome
9
2023
11821
0.200
Why?
Preoperative Care
2
2017
396
0.200
Why?
Pancreas
2
2023
343
0.190
Why?
Image Processing, Computer-Assisted
1
2007
778
0.190
Why?
Organoplatinum Compounds
3
2017
65
0.190
Why?
Leucovorin
3
2017
98
0.180
Why?
Patient Safety
1
2025
352
0.170
Why?
Proportional Hazards Models
4
2019
1331
0.170
Why?
Kaplan-Meier Estimate
3
2019
970
0.160
Why?
Medical Oncology
1
2024
345
0.160
Why?
Biliary Tract Neoplasms
1
2020
30
0.150
Why?
Adult
13
2024
41087
0.150
Why?
Male
18
2024
73396
0.140
Why?
Follow-Up Studies
5
2024
5439
0.140
Why?
Stomach
2
2016
106
0.140
Why?
Workflow
2
2020
182
0.140
Why?
Duodenum
2
2016
76
0.140
Why?
Technetium Tc 99m Aggregated Albumin
1
2018
6
0.140
Why?
Female
17
2024
79499
0.140
Why?
Serum Albumin, Human
1
2018
7
0.140
Why?
Bilirubin
1
2018
101
0.130
Why?
Rectum
3
2020
180
0.130
Why?
Observer Variation
2
2015
356
0.130
Why?
Chemoembolization, Therapeutic
1
2018
88
0.130
Why?
Matched-Pair Analysis
1
2017
38
0.130
Why?
Colon
2
2017
304
0.130
Why?
Precision Medicine
1
2021
462
0.120
Why?
Age Factors
2
2017
3347
0.120
Why?
Microspheres
1
2016
142
0.120
Why?
Pelvis
1
2017
129
0.110
Why?
Pelvic Neoplasms
1
2015
24
0.110
Why?
Camptothecin
1
2016
139
0.110
Why?
Retroperitoneal Neoplasms
1
2015
28
0.110
Why?
Liposarcoma
1
2015
31
0.110
Why?
ROC Curve
1
2017
617
0.110
Why?
Regression Analysis
1
2017
999
0.100
Why?
Lung
1
2007
4122
0.100
Why?
Radiation Injuries
1
2015
149
0.100
Why?
Prostate
2
2015
159
0.100
Why?
Retrospective Studies
9
2024
17438
0.100
Why?
Acute Disease
1
2017
1038
0.100
Why?
Practice Guidelines as Topic
2
2019
1591
0.100
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2013
20
0.090
Why?
Gastrointestinal Tract
1
2015
203
0.090
Why?
Feasibility Studies
1
2017
1135
0.090
Why?
Motion
1
2012
94
0.090
Why?
Thoracic Wall
1
2012
22
0.090
Why?
Patient Positioning
1
2012
73
0.090
Why?
Image Enhancement
1
2012
198
0.080
Why?
Karnofsky Performance Status
1
2011
37
0.080
Why?
Pneumonectomy
1
2013
169
0.080
Why?
Computer Systems
1
2011
54
0.080
Why?
Dose-Response Relationship, Radiation
1
2011
141
0.080
Why?
Rotation
1
2011
124
0.080
Why?
Neoplasm Invasiveness
1
2012
504
0.080
Why?
Patient Care Team
1
2016
701
0.080
Why?
Survival Rate
3
2024
2092
0.080
Why?
Carcinoembryonic Antigen
2
2022
40
0.080
Why?
Software
2
2016
676
0.080
Why?
Head and Neck Neoplasms
1
2015
563
0.080
Why?
Survival Analysis
1
2012
1378
0.070
Why?
Analysis of Variance
1
2011
1298
0.070
Why?
Capecitabine
2
2020
56
0.070
Why?
Inhalation
1
2007
28
0.070
Why?
Exhalation
1
2007
28
0.070
Why?
Sensitivity and Specificity
1
2012
1998
0.060
Why?
Quality Improvement
1
2016
1354
0.060
Why?
Artifacts
1
2007
143
0.060
Why?
Prognosis
2
2018
4351
0.060
Why?
Deoxycytidine
2
2019
219
0.060
Why?
Pain
1
2012
790
0.060
Why?
Bile Duct Neoplasms
1
2007
132
0.060
Why?
Cohort Studies
2
2016
6077
0.060
Why?
Esophagogastric Junction
1
2024
54
0.050
Why?
Reproducibility of Results
1
2012
3416
0.050
Why?
Quality of Life
1
2016
3200
0.050
Why?
Multivariate Analysis
2
2018
1543
0.050
Why?
Trypanosoma brucei rhodesiense
1
2002
1
0.050
Why?
Trypanocidal Agents
1
2002
2
0.050
Why?
Risk Assessment
1
2012
3712
0.050
Why?
Diphosphonates
1
2002
68
0.040
Why?
Albumins
1
2022
120
0.040
Why?
Paclitaxel
1
2022
260
0.040
Why?
Watchful Waiting
1
2021
90
0.040
Why?
Brachytherapy
1
2020
132
0.040
Why?
Magnetic Resonance Spectroscopy
1
2021
627
0.030
Why?
Quality Assurance, Health Care
1
2020
349
0.030
Why?
Aspartate Aminotransferases
1
2018
86
0.030
Why?
Tumor Suppressor Protein p53
1
2022
530
0.030
Why?
Time Factors
2
2018
7109
0.030
Why?
Lymphocytes
1
2018
379
0.030
Why?
Duodenal Ulcer
1
2016
12
0.030
Why?
Erlotinib Hydrochloride
1
2016
71
0.030
Why?
Equilibrative Nucleoside Transporter 1
1
2015
19
0.030
Why?
Peritoneal Cavity
1
2015
30
0.030
Why?
Clinical Trials as Topic
1
2020
1064
0.030
Why?
Perioperative Period
1
2015
69
0.030
Why?
Clinical Trials, Phase III as Topic
1
2015
116
0.030
Why?
Neutropenia
1
2016
153
0.030
Why?
Penis
1
2015
33
0.030
Why?
Academic Medical Centers
1
2018
561
0.030
Why?
United States
2
2025
16136
0.030
Why?
Anemia
1
2016
190
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1763
0.030
Why?
Thrombocytopenia
1
2016
206
0.030
Why?
Cisplatin
1
2016
347
0.020
Why?
Chemotherapy, Adjuvant
1
2015
429
0.020
Why?
Gastrointestinal Diseases
1
2016
220
0.020
Why?
Consensus
1
2015
467
0.020
Why?
Pancreatectomy
1
2016
289
0.020
Why?
Urinary Bladder
1
2015
194
0.020
Why?
Sarcoma
1
2015
209
0.020
Why?
Neutrophils
1
2018
1133
0.020
Why?
Liver
1
2021
1864
0.020
Why?
Treatment Failure
1
2013
361
0.020
Why?
Patient Satisfaction
1
2016
706
0.020
Why?
Neoplasm Metastasis
1
2013
693
0.020
Why?
Biomarkers
1
2021
4340
0.020
Why?
Predictive Value of Tests
1
2015
2113
0.020
Why?
Biopsy
1
2013
1075
0.020
Why?
Computer Simulation
1
2013
1014
0.020
Why?
Disease Progression
1
2016
2867
0.020
Why?
Logistic Models
1
2012
2126
0.020
Why?
Prospective Studies
1
2019
8123
0.010
Why?
Risk Factors
1
2018
10921
0.010
Why?
Postoperative Complications
1
2016
3034
0.010
Why?
Lethal Dose 50
1
2002
17
0.010
Why?
Quantitative Structure-Activity Relationship
1
2002
18
0.010
Why?
Quantum Theory
1
2002
87
0.010
Why?
Crystallography, X-Ray
1
2002
477
0.010
Why?
Tumor Cells, Cultured
1
2002
882
0.010
Why?
Models, Molecular
1
2002
1573
0.010
Why?
Animals
1
2002
38106
0.000
Why?
Olsen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)